NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 85 filers reported holding NGM BIOPHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $949,107 | -56.9% | 886,901 | +4.2% | 0.00% | – |
| Q2 2023 | $2,203,976 | -31.7% | 850,956 | +7.6% | 0.00% | – |
| Q1 2023 | $3,226,614 | +85759.9% | 790,837 | +5.6% | 0.00% | -100.0% |
| Q4 2022 | $3,758 | -100.0% | 748,724 | +1.5% | 0.00% | 0.0% |
| Q3 2022 | $9,644,000 | +3.3% | 737,316 | +1.2% | 0.00% | 0.0% |
| Q2 2022 | $9,340,000 | -12.8% | 728,614 | +3.7% | 0.00% | 0.0% |
| Q1 2022 | $10,710,000 | -13.4% | 702,314 | +0.6% | 0.00% | 0.0% |
| Q4 2021 | $12,361,000 | -8.7% | 697,974 | +8.4% | 0.00% | -50.0% |
| Q3 2021 | $13,534,000 | +19.2% | 643,873 | +11.8% | 0.00% | 0.0% |
| Q2 2021 | $11,354,000 | -14.8% | 575,796 | +25.6% | 0.00% | 0.0% |
| Q1 2021 | $13,323,000 | +27.3% | 458,313 | +32.6% | 0.00% | 0.0% |
| Q4 2020 | $10,467,000 | +118.4% | 345,517 | +14.7% | 0.00% | +100.0% |
| Q3 2020 | $4,793,000 | -0.6% | 301,259 | +23.3% | 0.00% | 0.0% |
| Q2 2020 | $4,824,000 | +66.7% | 244,380 | +4.1% | 0.00% | 0.0% |
| Q1 2020 | $2,894,000 | -58.2% | 234,788 | -37.3% | 0.00% | 0.0% |
| Q4 2019 | $6,918,000 | +429.3% | 374,182 | +296.2% | 0.00% | – |
| Q3 2019 | $1,307,000 | -10.0% | 94,431 | -4.8% | 0.00% | – |
| Q2 2019 | $1,452,000 | – | 99,181 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenspring Associates, LLC | 1,573,357 | $47,665,000 | 61.89% |
| RHO CAPITAL PARTNERS INC | 3,766,666 | $114,111,000 | 60.06% |
| Column Group LLC | 15,396,116 | $466,502,000 | 42.31% |
| Ponoi II Management, LLC | 1,298,908 | $39,357,000 | 28.68% |
| Ponoi Management, LLC | 1,298,908 | $39,357,000 | 22.52% |
| Euclidean Capital LLC | 2,083,602 | $63,133,000 | 13.36% |
| Aquilo Capital Management, LLC | 1,005,534 | $30,463,000 | 6.33% |
| Octagon Capital Advisors LP | 75,227 | $2,279,000 | 0.79% |
| Jasper Ridge Partners, L.P. | 308,750 | $9,354,000 | 0.41% |
| Point72 Asset Management, L.P. | 1,761,157 | $53,354,000 | 0.26% |